Renewable Trends And Specialties Will Shape Future Markets

Analysts have maintained their price target for Calumet at $19.05. They cite only minor adjustments to discount rate and valuation assumptions that do not materially alter their outlook for the company.

Calumet’s valuation outlook remains stable, with both the discount rate and future P/E changing only marginally, resulting in an unchanged consensus price target of $19.05. What's in the News Calumet received full or partial EPA exemptions on all small refinery petitions from 2019–2024, reducing its accrued RIN liability from 396 million to 89 million RINs. The company was added to multiple Russell indexes, including Russell 2000, 2500, 3000, and their respective growth and value variants, increasing its visibility to index funds and institutional investors.

Calumet’s valuation outlook remains steady, with both the discount rate and future P/E experiencing only marginal adjustments, resulting in the consensus analyst price target holding firm at $19.05. What's in the News EPA granted Calumet full or partial exemptions on all small refinery petitions from 2019–2024, reducing RIN liability from 396 million to 89 million RINs. Calumet was added to numerous Russell indexes, including Russell 2000, 2500, 3000, and related growth/value/small cap completeness benchmarks, increasing its visibility to institutional investors.

Despite a notable increase in consensus revenue growth forecasts for Calumet, a decline in net profit margin offset the improvement, resulting in an unchanged analyst price target of $19.05. What's in the News Calumet added to multiple Russell indices, including the Russell 2000, 2500, and 3000, as well as corresponding Growth and Value subsets.

Despite materially improving revenue growth and net profit margin forecasts, Calumet’s consensus analyst price target remains unchanged at $18.80. What's in the News Calumet, Inc.

Calumet’s fair value estimate was marginally reduced as analysts now expect markedly slower revenue growth and a higher future P/E, signaling a more cautious outlook on earnings growth. What's in the News Calumet, Inc.